Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Alkermes plc (ALKS) vs Lantheus Holdings, Inc. (LNTH)

Alkermes plc and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Alkermes plc and Lantheus Holdings, Inc. are of similar size ($6.8B and $6.5B). Lantheus Holdings, Inc. trades at the lower P/E: 23.7× against 101×. Alkermes plc grew revenue faster over the last twelve months: 10.8% against 2.35%. Lantheus Holdings, Inc. has the higher net margin (17.7% vs 3.97%) and the higher return on invested capital (14.7% vs 2.76%). Across the 21 metrics below, Lantheus Holdings, Inc. leads on 16 and Alkermes plc on 5.

Valuation

Metric ALKS LNTH Drug Manufacturers Specialty & Generic median
P/E 101.36 23.69 20.14
P/S 4.09 4.18 2.25
P/B 3.77 4.95 1.90
Price to free cash flow 30.64 16.54 16.54
EV/EBITDA 34.45 16.38 12.29
EV/Sales 4.60 4.16 2.56
Earnings yield 0.99% 4.22% (2.99%)
Free cash flow yield 3.26% 6.04% 0.00%

Profitability

Metric ALKS LNTH Drug Manufacturers Specialty & Generic median
Gross margin 84.56% 60.14% 53.94%
Operating margin 7.03% 19.43% 0.00%
Net margin 3.97% 17.69% 0.00%
Free cash flow margin 13.35% 25.24% 0.00%
Return on equity 3.85% 22.21% (0.40%)
Return on assets 1.99% 12.15% (3.32%)
Return on invested capital 2.76% 14.65% 0.00%

Growth

Metric ALKS LNTH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 10.79% 2.35% 10.01%
EPS growth (last fiscal year) (34.10%) (21.79%) —
Revenue growth, 5-year CAGR 7.28% 35.35% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALKS LNTH Drug Manufacturers Specialty & Generic median
Debt to equity 0.83 0.44 0.05
Current ratio 2.30 3.06 2.31
Net debt to EBITDA (4.69) 0.55 0.85

Dividend

Metric ALKS LNTH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ALKS LNTH Drug Manufacturers Specialty & Generic median
Market cap 6.78b 6.51b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack